Literature DB >> 7856762

Sarcoglycan complex is selectively lost in dystrophic hamster muscle.

Y Mizuno1, S Noguchi, H Yamamoto, M Yoshida, I Nonaka, S Hirai, E Ozawa.   

Abstract

We recently reported that the dystrophin-associated glycoprotein (DAG) complex is biochemically divided into two subcomplexes: one is the dystroglycan complex comprised of 156DAG and 43DAG and the other is the sarcoglycan complex comprised of 50DAG, A3b, and 35DAG. A3b is a novel dystrophin-associated glycoprotein with an approximate molecular mass of 43 kd but is distinct from 43DAG. In the present study, we examined the striated muscles of the dystrophic hamster with anti-A3b antibody in addition to anti-50DAG, anti-43DAG, anti-35DAG, anti-dystrophin, and anti-laminin antibodies by both immunohistochemistry and immunoblot analysis and found that 50DAG, A3b, and 35DAG are selectively lost. This selective defect of the sarcoglycan complex in dystrophic hamster muscles may give rise to dystrophic changes in striated muscles. Thus, the differentiation of the dystrophin-associated glycoprotein complex into the dystroglycan and sarcoglycan complexes is important not only from a biochemical standpoint but also in understanding the cause of muscular dystrophy in the hamster. Our findings further show that the dystrophic hamster may serve as an animal model for a human disease, severe childhood autosomal recessive muscular dystrophy, which has recently been shown to result from a selective defect in the sarcoglycan complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856762      PMCID: PMC1869857     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Heterogeneity of dystrophin-associated proteins.

Authors:  H Yamamoto; Y Hagiwara; Y Mizuno; M Yoshida; E Ozawa
Journal:  J Biochem       Date:  1993-07       Impact factor: 3.387

2.  Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart.

Authors:  Y Iwata; H Nakamura; Y Mizuno; M Yoshida; E Ozawa; M Shigekawa
Journal:  FEBS Lett       Date:  1993-08-23       Impact factor: 4.124

3.  Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle.

Authors:  Y Mizuno; S Noguchi; H Yamamoto; M Yoshida; A Suzuki; Y Hagiwara; Y K Hayashi; K Arahata; I Nonaka; S Hirai
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575

4.  Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis.

Authors:  M R Passos-Bueno; J R Oliveira; E Bakker; R D Anderson; S K Marie; M Vainzof; S Roberds; K P Campbell; M Zatz
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

5.  Dystrophin or a "related protein" in Duchenne muscular dystrophy?

Authors:  L V Nicholson; M A Johnson; K Davison; E O'Donnell; G Falkous; M Barron; J B Harris
Journal:  Acta Neurol Scand       Date:  1992-07       Impact factor: 3.209

6.  A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle.

Authors:  M Yoshida; Y Mizuno; I Nonaka; E Ozawa
Journal:  J Biochem       Date:  1993-11       Impact factor: 3.387

7.  Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy.

Authors:  Y Mizuno; M Yoshida; I Nonaka; S Hirai; E Ozawa
Journal:  Muscle Nerve       Date:  1994-02       Impact factor: 3.217

8.  Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDa dystrophin-associated glycoprotein maps to chromosome 13q12.

Authors:  K Azibi; L Bachner; J S Beckmann; K Matsumura; E Hamouda; M Chaouch; A Chaouch; R Ait-Ouarab; A Vignal; J Weissenbach
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

9.  Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.

Authors:  Y Mizuno; I Nonaka; S Hirai; E Ozawa
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

10.  Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster.

Authors:  S L Roberds; J M Ervasti; R D Anderson; K Ohlendieck; S D Kahl; D Zoloto; K P Campbell
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

View more
  9 in total

1.  Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors:  P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy.

Authors:  X Xiao; J Li; Y P Tsao; D Dressman; E P Hoffman; J F Watchko
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 3.  Creatine kinase, cell membrane and Duchenne muscular dystrophy.

Authors:  E Ozawa; Y Hagiwara; M Yoshida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster.

Authors:  V Straub; F Duclos; D P Venzke; J C Lee; S Cutshall; C J Leveille; K P Campbell
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

5.  Altered Ca2+ homeostasis and impaired mitochondrial function in cardiomyopathy.

Authors:  Tuan H Kuo; Liping Zhu; Kish Golden; James D Marsh; Syamal K Bhattacharya; Bei-Fang Liu
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

6.  Gait disturbances in dystrophic hamsters.

Authors:  Thomas G Hampton; Ajit Kale; Ivo Amende; Wenlong Tang; Scott McCue; Hemmi N Bhagavan; Case G VanDongen
Journal:  J Biomed Biotechnol       Date:  2011-01-13

7.  Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.

Authors:  R H Crosbie; C S Lebakken; K H Holt; D P Venzke; V Straub; J C Lee; R M Grady; J S Chamberlain; J R Sanes; K P Campbell
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

8.  Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology.

Authors:  Y W Chen; P Zhao; R Borup; E P Hoffman
Journal:  J Cell Biol       Date:  2000-12-11       Impact factor: 10.539

Review 9.  Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.

Authors:  Dorianna Sandonà; Romeo Betto
Journal:  Expert Rev Mol Med       Date:  2009-09-28       Impact factor: 5.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.